Angiosarcoma - Global Clinical Trials Review, H2, 2021
- $ 2500
- May 2024
- 126 pages
Adenocarcinoma, Adenoid Cystic Carcinoma (ACC), Adrenocortical Carcinoma (Adrenal Cortex Cancer), Anal Cancer, Angiosarcoma, Basal Cell Carcinoma (Basal Cell Epithelioma), Bile Duct Cancer (Cholangiocarcinoma) , Bladder Carcinoma, Brain Tumor, Breast Tumor, Carcinoid Tumor, Carcinomas, Cervical Cancer, Chordoma, Choriocarcinoma (Gestational Trophoblastic Neoplasia), Colon Cancer, Colorectal Cancer, Endometrial Cancer, Epithelial Tumor, Esophageal Cancer, Extrahepatic Bile Duct Cancer, Extramammary Paget Disease (EMPD), Fallopian Tube Cancer, Gallbladder Cancer, Gastric Cancer, Gastrointestinal Stromal Tumor (GIST), Gastrointestinal Tract Cancer, Gastrointestinal Tumor, Germ Cell Tumors, Gestational Trophoblastic Disease, Giant Cell Tumor Of Bone, Human Papillomavirus (HPV) Associated Cancer, Intestinal Cancer, Lip Cancer, Lung Adenocarcinoma, Lung Cancer, Malignant Neoplasms, Metastatic Breast Cancer, Nasopharyngeal Cancer, Neuroendocrine Carcinoma, Neuroendocrine Tumors, Oral Cavity (Mouth) Cancer, Oropharyngeal Cancer, Ovarian Cancer, Pancreatic Cancer, Papillary Tumor, Paraganglioma (Glomus Jugulare Tumor), Paranasal Sinus And Nasal Cavity Cancer, Peripheral Nerve Sheath Tumor (Neurofibrosarcoma), Peritoneal Tumor, Pheochromocytoma, Pituitary Tumor, Rectal Cancer, Salivary Gland Cancer, Skin Cancer, Small Intestine Cancer, Solid Tumor, Spindle Cell Squamous Cell Carcinoma , Squamous Cell Carcinoma, Testicular Cancer, Thyroid Cancer, Transitional Cell Carcinoma (Urothelial Cell Carcinoma), Unspecified Rare Disease, Ureter Cancer, Urethral Cancer, Vaginal Cancer, Vulvar Cancer